DESOGESTREL AND ETHINYL ESTRADIOL

Desogestrel And Ethinyl Estradiol Adverse Events Reported to the FDA Over Time

How are Desogestrel And Ethinyl Estradiol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Desogestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Desogestrel And Ethinyl Estradiol is flagged as the suspect drug causing the adverse event.

Most Common Desogestrel And Ethinyl Estradiol Adverse Events Reported to the FDA

What are the most common Desogestrel And Ethinyl Estradiol adverse events reported to the FDA?

Pulmonary Embolism	38 (2.57%)
Drug Interaction	34 (2.3%)
Headache	25 (1.69%)
Inappropriate Schedule Of Drug Admi...	25 (1.69%)
Nausea	24 (1.62%)
Vomiting	24 (1.62%)
Pregnancy On Oral Contraceptive	21 (1.42%)
Abortion Spontaneous	16 (1.08%)
Loss Of Consciousness	16 (1.08%)
Malaise	16 (1.08%)
Drug Exposure During Pregnancy	15 (1.01%)
	Show More
Deep Vein Thrombosis	14 (.95%)
Weight Increased	14 (.95%)
Abdominal Pain	13 (.88%)
Alopecia	13 (.88%)
Back Pain	13 (.88%)
Hypertension	13 (.88%)
Drug Dose Omission	12 (.81%)
Memory Impairment	12 (.81%)
Migraine	12 (.81%)
Off Label Use	12 (.81%)
Cardio-respiratory Arrest	11 (.74%)
Fatigue	11 (.74%)
Hypoaesthesia	11 (.74%)
Menstruation Irregular	11 (.74%)
Thrombosis	11 (.74%)
Cardiac Arrest	10 (.68%)
Diarrhoea	10 (.68%)
Dyspnoea	10 (.68%)
Fall	10 (.68%)
Metrorrhagia	10 (.68%)
Pain In Extremity	10 (.68%)
Vaginal Haemorrhage	10 (.68%)
Chest Pain	9 (.61%)
Condition Aggravated	9 (.61%)
Pain	9 (.61%)
Palpitations	9 (.61%)
Paraesthesia	9 (.61%)
Cerebral Haemorrhage	8 (.54%)
Dizziness	8 (.54%)
Intracranial Pressure Increased	8 (.54%)
Muscle Spasms	8 (.54%)
Ovarian Cyst Ruptured	8 (.54%)
Amenorrhoea	7 (.47%)
Asthenia	7 (.47%)
Brain Oedema	7 (.47%)
Dysmenorrhoea	7 (.47%)
Hypothyroidism	7 (.47%)
Pregnancy	7 (.47%)
Urinary Tract Infection	7 (.47%)
Brain Hypoxia	6 (.41%)
Cerebral Venous Thrombosis	6 (.41%)
Enteritis	6 (.41%)
Intracranial Venous Sinus Thrombosi...	6 (.41%)
Neck Pain	6 (.41%)
Nephrolithiasis	6 (.41%)
Oedema Peripheral	6 (.41%)
Ovarian Cyst	6 (.41%)
Peritoneal Haemorrhage	6 (.41%)
Pneumonia	6 (.41%)
Tachycardia	6 (.41%)
Thrombophlebitis	6 (.41%)
Abdominal Pain Upper	5 (.34%)
Death	5 (.34%)
Drug Hypersensitivity	5 (.34%)
Dry Mouth	5 (.34%)
Epilepsy	5 (.34%)
Gastritis	5 (.34%)
Incorrect Dose Administered	5 (.34%)
Klebsiella Infection	5 (.34%)
Liver Disorder	5 (.34%)
Menorrhagia	5 (.34%)
Product Substitution Issue	5 (.34%)
Serotonin Syndrome	5 (.34%)
Stress	5 (.34%)
Swelling	5 (.34%)
Visual Acuity Reduced	5 (.34%)
Vulvovaginal Burning Sensation	5 (.34%)
Accommodation Disorder	4 (.27%)
Alanine Aminotransferase Increased	4 (.27%)
Anaemia	4 (.27%)
Anxiety	4 (.27%)
Aspartate Aminotransferase Increase...	4 (.27%)
Bronchitis	4 (.27%)
Caesarean Section	4 (.27%)
Cholelithiasis	4 (.27%)
Depression	4 (.27%)
Drug Withdrawal Syndrome	4 (.27%)
Dyspepsia	4 (.27%)
Epistaxis	4 (.27%)
Gait Disturbance	4 (.27%)
Hypotension	4 (.27%)
Increased Appetite	4 (.27%)
Jugular Vein Thrombosis	4 (.27%)
Leiomyoma	4 (.27%)
Lung Disorder	4 (.27%)
Menstruation Delayed	4 (.27%)
Myocardial Infarction	4 (.27%)
No Adverse Event	4 (.27%)
Pulmonary Infarction	4 (.27%)
Subarachnoid Haemorrhage	4 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Desogestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Desogestrel And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Desogestrel And Ethinyl Estradiol

What are the most common Desogestrel And Ethinyl Estradiol adverse events reported to the FDA?

Gastrointestinal Signs	76 (5.14%)
Neurological	70 (4.73%)
Menstrual Cycle And Uterine Bleedin...	52 (3.51%)
Medication Errors	49 (3.31%)
Embolism And Thrombosis	45 (3.04%)
Pulmonary Vascular	45 (3.04%)
Therapeutic And Nontherapeutic Effe...	44 (2.97%)
Central Nervous System Vascular	43 (2.91%)
Infections - Pathogen Unspecified	39 (2.64%)
Headaches	38 (2.57%)
Cardiac Arrhythmias	33 (2.23%)
	Show More
Musculoskeletal And Connective Tiss...	33 (2.23%)
Respiratory	33 (2.23%)
Pregnancy, Labour, Delivery And Pos...	32 (2.16%)
Hepatic And Hepatobiliary	27 (1.82%)
Vision	20 (1.35%)
Abortions And Stillbirth	19 (1.28%)
Chemical Injury And Poisoning	19 (1.28%)
Injuries	19 (1.28%)
Ovarian And Fallopian Tube	18 (1.22%)
Skin Appendage Conditions	18 (1.22%)
Breast	17 (1.15%)
Vulvovaginal Disorders	17 (1.15%)
Hematology Investigations	16 (1.08%)
Physical Examination Topics	16 (1.08%)
Coronary Artery	15 (1.01%)
Epidermal And Dermal Conditions	15 (1.01%)
Increased Intracranial Pressure And...	15 (1.01%)
Therapeutic Procedures And Supporti...	15 (1.01%)
Anxiety Disorders	13 (.88%)
Gastrointestinal Inflammatory Condi...	13 (.88%)
Mental Impairment	13 (.88%)
Muscle	13 (.88%)
Vascular Hypertensive	13 (.88%)
Cardiac Disorder Signs	12 (.81%)
Gastrointestinal Motility And Defec...	12 (.81%)
Allergic Conditions	11 (.74%)
Bacterial Infectious	11 (.74%)
Appetite And General Nutritional	10 (.68%)
Cardiac And Vascular Investigations	10 (.68%)
Movement Disorders	10 (.68%)
Renal Disorders	10 (.68%)
Hepatobiliary	9 (.61%)
Maternal Complications Of Pregnancy	9 (.61%)
Obstetric And Gynecological Therape...	9 (.61%)
Thyroid Gland	9 (.61%)
Urinary Tract Signs	9 (.61%)
Ocular Neuromuscular	8 (.54%)
Administration Site Reactions	7 (.47%)
Fatal Outcomes	7 (.47%)
Joint	7 (.47%)
Seizures	7 (.47%)
Soft Tissue Neoplasms Benign	7 (.47%)
Depressed Mood Disorders	6 (.41%)
Endocrine Investigations	6 (.41%)
Gallbladder	6 (.41%)
Lower Respiratory Tract Disorders	6 (.41%)
Neuromuscular	6 (.41%)
Peritoneal And Retroperitoneal Cond...	6 (.41%)
Urolithiases	6 (.41%)
Vascular	6 (.41%)
Anemias Nonhemolytic And Marrow Dep...	5 (.34%)
Decreased And Nonspecific Blood Pre...	5 (.34%)
Inner Ear And Viiith Cranial Nerve	5 (.34%)
Mood Disorders	5 (.34%)
Peripheral Neuropathies	5 (.34%)
Platelet	5 (.34%)
Product Quality Issues	5 (.34%)
Salivary Gland Conditions	5 (.34%)
Spleen, Lymphatic And Reticulendoth...	5 (.34%)
Upper Respiratory Tract Disorders	5 (.34%)
Uterine, Pelvic And Broad Ligament	5 (.34%)
Coagulopathies And Bleeding Diathes...	4 (.27%)
Eye	4 (.27%)
Metabolic, Nutritional And Blood Ga...	4 (.27%)
Neurological, Special Senses And Ps...	4 (.27%)
Psychiatric	4 (.27%)
Reproductive Neoplasms Female Malig...	4 (.27%)
Skin Vascular Abnormalities	4 (.27%)
Ancillary Infectious Topics	3 (.2%)
Aneurysms And Artery Dissections	3 (.2%)
Arteriosclerosis, Stenosis, Vascula...	3 (.2%)
Body Temperature Conditions	3 (.2%)
Changes In Physical Activity	3 (.2%)
Demyelinating	3 (.2%)
Enzyme	3 (.2%)
Fungal Infectious	3 (.2%)
Gastrointestinal Conditions	3 (.2%)
Heart Failures	3 (.2%)
Lifestyle Issues	3 (.2%)
Sexual Dysfunctions, Disturbances A...	3 (.2%)
Sleep Disorders	3 (.2%)
Tendon, Ligament And Cartilage	3 (.2%)
Tissue	3 (.2%)
Blood And Lymphatic System Disorder...	2 (.14%)
Cranial Nerve Disorders	2 (.14%)
Disturbances In Thinking	2 (.14%)
Endocrine Neoplasms Malignant And U...	2 (.14%)
Exocrine Pancreas Conditions	2 (.14%)
Gastrointestinal Therapeutic Proced...	2 (.14%)
Hemolyses And Related Conditions	2 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Desogestrel And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Desogestrel And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.